文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

小鼠与人类脓毒症中内皮通透性调节分子反应存在器官特异性差异

Organ-Specific Differences in Endothelial Permeability-Regulating Molecular Responses in Mouse and Human Sepsis.
PubMed 文献 · Shock · 2017-01-01
一句话结论脓毒症时肺与肾对内皮通透性调节分子的反应方向不同:肺表达谱符合通透性增加,肾表达谱符合通透性降低。

该研究探讨脓毒症相关器官功能障碍中,肺与肾水肿形成和功能丧失模式不同的分子基础。作者用定量实时聚合酶链反应检测小鼠腹腔注射脂多糖后肾和肺中一组预设的内皮通透性相关分子(occludin、claudin-5、PV-1、CD-31、endomucin、Angiopoietin-1、Angiopoietin-2、Tie2、VEGFA、VEGFR1、VEGFR2、VE-cadherin)的表达,并检测死于脓毒症患者的肾组织。结果显示小鼠肾与肺基线内皮通透性相关分子表达不同,脂多糖注射后两器官表达调控也不同:肺中黏附连接和紧密连接复合物及相关信号系统分子表达水平下降,符合通透性增加;肾中这些分子表达模式符合通透性降低。作者在人类脓毒症患者肾中部分印证了小鼠肾的发现。这些发现可能有助于理解脓毒症相关器官衰竭时肺与肾水肿程度不同的临床差异。

要点

  • 小鼠肾与肺基线内皮通透性相关分子表达存在器官差异,脂多糖注射后两器官表达调控模式不同。
  • 小鼠肺在脂多糖注射后黏附连接和紧密连接复合物及相关信号系统分子表达水平下降,符合通透性增加。
  • 小鼠肾在脂多糖注射后上述分子表达模式符合通透性降低。
  • 人类脓毒症患者肾组织中部分印证了小鼠肾的发现。
  • 作者认为这些发现可能有助于理解脓毒症相关器官衰竭时肺与肾水肿程度不同的临床差异。

适用人群与场景

  • 小鼠:系统性脂多糖注射后的肾和肺组织。
  • 人类:死于脓毒症患者的肾组织。

研究设计与关键结果

  • 研究类型:动物实验加人类组织分析;方法:定量实时聚合酶链反应检测预设的内皮通透性相关分子(occludin、claudin-5、PV-1、CD-31、endomucin、Angiopoietin-1、Angiopoietin-2、Tie2、VEGFA、VEGFR1、VEGFR2、VE-cadherin)表达。
  • 小鼠肾与肺基线内皮通透性相关分子表达不同。
  • 小鼠脂多糖注射后两器官上述分子表达调控不同:肺中黏附连接和紧密连接复合物及相关信号系统分子表达水平下降,符合通透性增加;肾中表达模式符合通透性降低。
  • 人类脓毒症患者肾组织中部分印证了小鼠肾的发现。

证据类型、等级与局限

  • 证据类型:动物实验与人类组织分析(非随机对照试验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In patients with sepsis-induced multi-organ dysfunction syndrome, diverging patterns of oedema formation and loss of function in organs such as lung and kidney suggest that endothelial permeability-regulating molecular responses are differentially regulated. This potential differential regulation has been insufficiently studied at the level of components of adherens and tight junctions. We hypothesized that such a regulation by endothelial cells in sepsis takes place in an organ-specific manner. We addressed our hypothesis by studying by quantitative real time polymerase chain reaction the expression of a predefined subset of EC permeability-related molecules (occludin, claudin-5, PV-1, CD-31, endomucin, Angiopoietin-1, Angiopoietin-2, Tie2, VEGFA, VEGFR1, VEGFR2, and VE-cadherin) in kidney and lung after systemic lipopolysacharide injection in mice, and in kidneys of patients who died of sepsis. We showed that baseline endothelial expression of permeability-related molecules differs in mouse kidney and lung. Moreover, we showed differential regulation of these molecules after lipopolysacharide injection in the two mouse organs. In lung we found a decrease in expression levels of molecules of the adherence and tight junctions complex and related signaling systems, compatible with increased permeability. In contrast, in kidney we found expression patterns of these molecules compatible with decreased permeability. Finally, we partially corroborated our findings in mouse kidney in human kidneys from septic patients. These findings may help to understand the clinical difference in the extent of oedema formation in kidney and lung in sepsis-associated organ failure.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Aslan A, van Meurs M, Moser J, et al. Organ-Specific Differences in Endothelial Permeability-Regulating Molecular Responses in Mouse and Human Sepsis. Shock. 2017. PMID: 28151770. doi:10.1097/SHK.0000000000000841

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。